CymitQuimica logo
Hck

Hck

Hck inhibitors are compounds that target Hematopoietic Cell Kinase (Hck), a member of the Src family of tyrosine kinases involved in immune response regulation, cell growth, and differentiation. Hck is implicated in various diseases, including leukemia, inflammation, and immune disorders. Inhibitors of Hck are essential for exploring the role of this kinase in disease progression and therapeutic intervention. At CymitQuimica, we provide Hck inhibitors to support your research in immunology, oncology, and signal transduction.

Found 3 products of "Hck"

Sort by
Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
  • Hck-IN-1
    Targetmol
    + Info

    Hck-IN-1

    CAS:
    <p>Hck-IN-1 selectively inhibits Nef:Hck, IC50: 2.8 μM; &gt;20 μM for Hck alone. Potent HIV-1 Nef antagonist, IC50: 100-300 nM for HIV-1 replication.</p>
    Formula:C16H11ClN6O3S
    Purity:99.07%
    Color and Shape:Solid
    Molecular weight:402.81

    Ref: TM-T11538

  • iHCK-37
    Targetmol
    + Info

    iHCK-37

    CAS:
    <p>iHCK-37 (ASN05260065) is an Hck inhibitor with antitumor activity and blocks HIV-1 replication, used in chronic myelogenous leukemia (CML) research.</p>
    Formula:C30H32N4O2S2
    Purity:99.97%
    Color and Shape:Solid
    Molecular weight:544.73

    Ref: TM-T40594

  • TL02-59
    Targetmol
    + Info

    TL02-59

    CAS:
    <p>TL02-59: Fgr inhibitor (IC50=0.03nM), also targets Lyn (0.1nM), Hck (160nM), halts acute myelogenous leukemia growth.</p>
    Formula:C32H34F3N5O4
    Purity:98.77%
    Color and Shape:Solid
    Molecular weight:609.64

    Ref: TM-T13186